GenQA

EQAs

GenQA provides a wide range of genomic external quality assessments (EQAs) for both laboratory based services, clinical genetics centres and individual assessment.
Full details of all EQAs availabe can be accessed by clicking on the relevant links below.

All EQAs scheduled for release during April, May and June 2020 are now POSTPONED. Details of the revised timetable are available HERE

Last updated: Monday, 08 June 2020

2020 Acquired array (CLL and MDS) DNA analysis of haematological cases (CLL and myeloid) for the detection of recurrent and non-recurrent abnormalities. Array and NGS can be undertaken for copy number loss and gain. Read more	2020 Acute Lymphoblastic Leukaemia (ALL) Online analysis of interphase FISH and G-banded images for the detection of recurrent and non-recurrent abnormalities associated with haematological disease. Other tests, as applicable, to interpret the results e.g. FISH. Read more
2020 Amniotic fluid (AF) Online analysis of G-banded metaphase images, and other tests, as applicable, to analyse for aneuploidy and rearrangements. Read more	2020 Ataxias and Hereditary Spastic Paraplegia (HSP) Molecular testing for adult onset and childhood onset ataxias (including Hereditary spastic paraplegia). Read more
2020 Blood - postnatal Online analysis for the detection of aneuploidy and rearrangements. G-banded metaphase images and other tests, as applicable. Read more	2020 BRCA testing in ovarian cancer - germline Testing for germline BRCA1 and BRCA2 variants in ovarian cancer. Read more
2020 BRCA testing in ovarian cancer - somatic Testing for somatic BRCA1 and BRCA2 variants in ovarian cancer. Read more	2020 Cardiac Disorders Molecular testing for disorders associated with arrhythmia, cardiomyopathies and aortic dissection. Read more
2020 Central Nervous System (CNS) Tumours Testing for 1p/19q co-deletion status and MGMT promotor methylation and IDH1 / IDH2 status. Additional test information is provided for each case. Read more	2020 cfDNA testing for EGFR mutations in lung cancer Circulating free DNA(cfDNA) testing for EGFR variant in plasma for lung cancer . Three samples to be sent out of articifical plasma. Read more

Pages